1
/
of
0
FDA Drug Approval, A210317, OCTREOTIDE ACETATE
FDA Drug Approval, A210317, OCTREOTIDE ACETATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 210317
Company: TEVA PHARMS USA INC
Drug Name: OCTREOTIDE ACETATE
Active Ingredients: OCTREOTIDE ACETATE
Strength: EQ 30MG BASE/VIAL
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/05/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Company: TEVA PHARMS USA INC
Drug Name: OCTREOTIDE ACETATE
Active Ingredients: OCTREOTIDE ACETATE
Strength: EQ 30MG BASE/VIAL
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/05/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details